TELOGENIS Blog
Evidence-based analysis of cycloastragenol, telomerase science, NMN comparison, and longevity research. Every claim traceable to PubMed.
Cycloastragenol vs NMN: A Science-Based Comparison
A head-to-head analysis of two leading longevity compounds. CAG targets telomerase via hTERT upregulation; NMN restores NAD+ through the NAMPT pathway. We examine human RCT data, bioavailability challenges, and why they may be complementary rather than competitive.
Read article →